Search

everythinglearnresearchcommunity

for

Search:↓

A man with both Klinefelter syndrome and primary hyperparathyroidism showed a rare combination of symptoms and genetic patterns.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Women with PCOS have a higher chance of experiencing depression, anxiety, and sleep disorders.

High doses of cyproterone acetate are linked to an increased risk of developing meningioma.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

Premature hair graying in young Turkish adults is more likely if they have stress, a family history of graying, drink alcohol, have chronic diseases, are older, or are taller.

Systemic retinoids are effective for psoriasis but have side effects; benefits may outweigh risks, especially when reducing cancer risks from other treatments.

Breathing in high levels of certain air pollutants significantly increases women's risk of developing Polycystic Ovary Syndrome.

Metabolic syndrome linked to urinary symptoms; hair loss not significant.

Valproic acid increases the risk of hair loss more than other drugs, especially in migraine patients, and lamotrigine may be a safer alternative.

Most doctors know the thrombosis risk with Cyproterone/Ethinylestradiol, but some lack details on less common risks and patient instructions; educational materials are underused but useful.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

Finasteride may increase the risk of depression, anxiety, and suicidal thoughts.

Starting 5-alpha reductase inhibitors does not significantly increase the risk of rhabdomyolysis in older men, but is linked to a higher risk of muscle conditions.

Taking 5 alpha reductase inhibitor medication slightly increases the risk of depression, especially as you get older.

Finasteride doesn't raise acute pancreatitis risk.

Lurasidone is effective for bipolar depression and schizophrenia, but more safety data is needed.

CD133+ progenitor cells have therapeutic potential for diabetic ulcers and heart attack recovery, with manageable risks.

Bupropion causes more hair loss than other antidepressants, with paroxetine causing the least.

Weight loss and low folic acid levels after sleeve gastrectomy can predict hair loss severity.

Using 5-alpha reductase inhibitors may lower the risk of breast cancer in females.

Men taking dutasteride may have a higher risk of age-related macular degeneration.

Low HDL-C, uric acid, and 25-hydroxyvitamin D are risk factors for early-onset male hair loss.

Vaccination and timely treatment reduce the risk of long COVID.

Physical activity, height, and smoking affect prostate cancer risk.

Long-term diabetes, smoking, and poor blood sugar control increase the risk of artery disease in diabetic retinopathy patients.

Women with PCOS are at higher risk for gum disease, and managing shared risk factors can help both conditions.

Age, stress, and anger increase the risk of hair fall.